{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:53:06Z","timestamp":1787003586064,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Proyectos de investigaci\u00f3n en salud, Instituto Carlos III, Ministry of Science, Innovation and Universities, Spanish Government","award":["PI19\/01807"],"award-info":[{"award-number":["PI19\/01807"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-69205-w","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T07:02:04Z","timestamp":1723532524000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Identification of Chagas disease biomarkers using untargeted metabolomics"],"prefix":"10.1038","volume":"14","author":[{"given":"Alfonso","family":"Herreros-Cabello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pau","family":"Bosch-Nicolau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"P\u00e9rez-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Monge-Maillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose F.","family":"Rodriguez-Palomares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Luiz Pinho","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"S\u00e1nchez-Montalv\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester Cerdeira","family":"Sabino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca F.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Fresno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Giron\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"key":"69205_CR1","unstructured":"Chagas disease in Latin America: an epidemiological update based on 2010 estimates. Wkly Epidemiol Rec 90, 33\u201343 (2015)."},{"key":"69205_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","volume":"391","author":"JA P\u00e9rez-Molina","year":"2018","unstructured":"P\u00e9rez-Molina, J. A. & Molina, I. Chagas disease. Lancet 391, 82\u201394 (2018).","journal-title":"Lancet"},{"key":"69205_CR3","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"BJ Maron","year":"2006","unstructured":"Maron, B. J. et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113, 1807\u20131816 (2006).","journal-title":"Circulation"},{"key":"69205_CR4","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.4269\/ajtmh.16-0761","volume":"97","author":"PA Sales","year":"2017","unstructured":"Sales, P. A. et al. Experimental and clinical treatment of chagas disease: A review. Am. J. Trop Med. Hyg. 97, 1289\u20131303 (2017).","journal-title":"Am. J. Trop Med. Hyg."},{"key":"69205_CR5","doi-asserted-by":"publisher","first-page":"e0010386","DOI":"10.1371\/journal.pntd.0010386","volume":"16","author":"C Crespillo-And\u00fajar","year":"2022","unstructured":"Crespillo-And\u00fajar, C. et al. Use of benznidazole to treat chronic Chagas disease: An updated systematic review with a meta-analysis. PLoS Negl. Trop Dis. 16, e0010386 (2022).","journal-title":"PLoS Negl. Trop Dis."},{"key":"69205_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139363","author":"Y Sguassero","year":"2015","unstructured":"Sguassero, Y. et al. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A systematic review of follow-up Studies. PLoS One https:\/\/doi.org\/10.1371\/journal.pone.0139363 (2015).","journal-title":"PLoS One"},{"key":"69205_CR7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00216-021-03586-z","volume":"414","author":"FA Castelli","year":"2022","unstructured":"Castelli, F. A. et al. Metabolomics for personalized medicine: the input of analytical chemistry from biomarker discovery to point-of-care tests. Anal. Bioanal. Chem. 414, 759\u2013789 (2022).","journal-title":"Anal. Bioanal. Chem."},{"key":"69205_CR8","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.numecd.2021.01.008","volume":"31","author":"A Di Minno","year":"2021","unstructured":"Di Minno, A., Gelzo, M., Stornaiuolo, M., Ruoppolo, M. & Castaldo, G. The evolving landscape of untargeted metabolomics. Nutr. Metab. Cardiovasc. Dis. 31, 1645\u20131652 (2021).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"69205_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003337","author":"N Giron\u00e8s","year":"2014","unstructured":"Giron\u00e8s, N. et al. Global metabolomic profiling of acute myocarditis caused by Trypanosoma cruzi infection. PLoS Negl. Trop Dis. https:\/\/doi.org\/10.1371\/journal.pntd.0003337 (2014).","journal-title":"PLoS Negl. Trop Dis."},{"key":"69205_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810456","author":"ML D\u00edaz","year":"2022","unstructured":"D\u00edaz, M. L. et al. Metabolomic Profiling of End-Stage Heart Failure Secondary to Chronic Chagas Cardiomyopathy. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms231810456 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"69205_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0258622","author":"LE Echeverr\u00eda","year":"2021","unstructured":"Echeverr\u00eda, L. E. et al. Cardiovascular biomarkers as predictors of adverse outcomes in chronic Chagas cardiomyopathy. PLoS One https:\/\/doi.org\/10.1371\/journal.pone.0258622 (2021).","journal-title":"PLoS One"},{"key":"69205_CR12","doi-asserted-by":"publisher","first-page":"e1054","DOI":"10.1161\/CIR.0000000000000490","volume":"135","author":"SL Chow","year":"2017","unstructured":"Chow, S. L. et al. Role of biomarkers for the prevention, assessment, and management of heart failure: A scientific statement from the American heart association. Circulation 135, e1054\u2013e1091 (2017).","journal-title":"Circulation"},{"key":"69205_CR13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004361","author":"L Shen","year":"2017","unstructured":"Shen, L. et al. Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy. Circ. Heart Fail https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.117.004361 (2017).","journal-title":"Circ. Heart Fail"},{"key":"69205_CR14","doi-asserted-by":"publisher","first-page":"654","DOI":"10.4330\/wjc.v13.i12.654","volume":"13","author":"RM Saraiva","year":"2021","unstructured":"Saraiva, R. M. et al. Chagas heart disease: An overview of diagnosis, manifestations, treatment, and care. World J. Cardiol. 13, 654\u2013675 (2021).","journal-title":"World J. Cardiol."},{"key":"69205_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00269","author":"L Linhares-Lacerda","year":"2018","unstructured":"Linhares-Lacerda, L. et al. Circulating plasma microRNA-208a as potential biomarker of chronic indeterminate phase of chagas disease. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2018.00269 (2018).","journal-title":"Front Microbiol."},{"key":"69205_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00726-009-0269-0","volume":"37","author":"G Wu","year":"2009","unstructured":"Wu, G. Amino acids: metabolism, functions, and nutrition. Amino Acids 37, 1\u201317 (2009).","journal-title":"Amino Acids"},{"key":"69205_CR17","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.cell.2020.02.016","volume":"180","author":"I Nemet","year":"2020","unstructured":"Nemet, I. et al. A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors. Cell 180, 862-877.e22 (2020).","journal-title":"Cell"},{"key":"69205_CR18","doi-asserted-by":"publisher","first-page":"E009972","DOI":"10.1161\/CIRCHEARTFAILURE.122.009972","volume":"16","author":"KA Romano","year":"2023","unstructured":"Romano, K. A. et al. Gut microbiota-generated Phenylacetylglutamine and heart failure. Circ. Heart Fail 16, E009972 (2023).","journal-title":"Circ. Heart Fail"},{"key":"69205_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/metabo10110437","volume":"10","author":"HY Tang","year":"2020","unstructured":"Tang, H. Y. et al. Characteristic of metabolic status in heart failure and its impact in outcome perspective. Metabolites 10, 1\u201314 (2020).","journal-title":"Metabolites"},{"key":"69205_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21030790","author":"MC Velasquez-Martinez","year":"2020","unstructured":"Velasquez-Martinez, M. C., Santos-Vera, B., Velez-Hernandez, M. E., Vazquez-Torres, R. & Jimenez-Rivera, C. A. Alpha-1 Adrenergic Receptors Modulate Glutamate and GABA Neurotransmission onto Ventral Tegmental Dopamine Neurons during Cocaine Sensitization. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21030790 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"69205_CR21","doi-asserted-by":"publisher","first-page":"109795","DOI":"10.1016\/j.intimp.2023.109795","volume":"116","author":"H Fu","year":"2023","unstructured":"Fu, H., Kong, B., Zhu, J., Huang, H. & Shuai, W. Phenylacetylglutamine increases the susceptibility of ventricular arrhythmias in heart failure mice by exacerbated activation of the TLR4\/AKT\/mTOR signaling pathway. Int. Immunopharmacol. 116, 109795 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"69205_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.1076806","author":"Z Zhang","year":"2023","unstructured":"Zhang, Z. et al. Alteration of the gut microbiota and metabolite phenylacetylglutamine in patients with severe chronic heart failure. Front. Cardiovasc. Med. https:\/\/doi.org\/10.3389\/fcvm.2022.1076806 (2023).","journal-title":"Front. Cardiovasc. Med."},{"key":"69205_CR23","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1182\/blood-2010-08-300301","volume":"117","author":"T Riedel","year":"2011","unstructured":"Riedel, T. et al. Fibrinopeptides A and B release in the process of surface fibrin formation. Blood 117, 1700\u20131705 (2011).","journal-title":"Blood"},{"key":"69205_CR24","doi-asserted-by":"crossref","unstructured":"Coradin, T., Wang, K., Law, T. & Trichet, L. Type I Collagen-Fibrin Mixed Hydrogels: Preparation, Properties and Biomedical Applications. Gels 2020, Vol. 6, Page 36 6, 36 (2020).","DOI":"10.3390\/gels6040036"},{"key":"69205_CR25","doi-asserted-by":"publisher","first-page":"568","DOI":"10.2119\/molmed.2010.00146","volume":"17","author":"C Jennewein","year":"2011","unstructured":"Jennewein, C. et al. Novel aspects of fibrin(ogen) fragments during inflammation. Mol. Med. 17, 568\u2013573 (2011).","journal-title":"Mol. Med."},{"key":"69205_CR26","unstructured":"Fromentin, S. et al. Microbiome and metabolome features of the cardiometabolic disease spectrum. Nature Medicine 2022 28:2 28, 303\u2013314 (2022)."},{"key":"69205_CR27","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1097\/HJH.0000000000002363","volume":"38","author":"WJ He","year":"2020","unstructured":"He, W. J. et al. An untargeted metabolomics study of blood pressure: findings from the Bogalusa Heart Study. J. Hypertens 38, 1302\u20131311 (2020).","journal-title":"J. Hypertens"},{"key":"69205_CR28","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1002\/hep.29599","volume":"67","author":"R Fujiwara","year":"2018","unstructured":"Fujiwara, R. et al. Systemic regulation of bilirubin homeostasis: Potential benefits of hyperbilirubinemia. Hepatology 67, 1609\u20131619 (2018).","journal-title":"Hepatology"},{"key":"69205_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193041","author":"S Suh","year":"2018","unstructured":"Suh, S. et al. Relationship between serum bilirubin levels and cardiovascular disease. PLoS One https:\/\/doi.org\/10.1371\/journal.pone.0193041 (2018).","journal-title":"PLoS One"},{"key":"69205_CR30","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007792","author":"VC Marconi","year":"2018","unstructured":"Marconi, V. C. et al. Bilirubin Is Inversely Associated With Cardiovascular Disease Among HIV-Positive and HIV-Negative Individuals in VACS (Veterans Aging Cohort Study). J. Am. Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.117.007792 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"69205_CR31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cca.2017.11.013","volume":"476","author":"M Ozeki","year":"2018","unstructured":"Ozeki, M. et al. High serum bilirubin is associated with lower prevalence of peripheral arterial disease among cardiac patients. Clin. Chim. Acta 476, 60\u201366 (2018).","journal-title":"Clin. Chim. Acta"},{"key":"69205_CR32","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/ehf2.12453","volume":"6","author":"M Stenemo","year":"2019","unstructured":"Stenemo, M. et al. The metabolites urobilin and sphingomyelin (30:1) are associated with incident heart failure in the general population. ESC Heart Fail 6, 764\u2013773 (2019).","journal-title":"ESC Heart Fail"},{"key":"69205_CR33","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.cell.2018.07.019","volume":"174","author":"JS Lee","year":"2018","unstructured":"Lee, J. S. et al. Urea cycle dysregulation generates clinically relevant genomic and biochemical signatures. Cell 174, 1559-1570.e22 (2018).","journal-title":"Cell"},{"key":"69205_CR34","doi-asserted-by":"publisher","first-page":"909","DOI":"10.2215\/CJN.00320106","volume":"1","author":"W Musch","year":"2006","unstructured":"Musch, W., Verfaillie, L. & Decaux, G. Age-related increase in plasma urea level and decrease in fractional urea excretion: clinical application in the syndrome of inappropriate secretion of antidiuretic hormone. Clin. J. Am. Soc. Nephrol. 1, 909\u2013914 (2006).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"69205_CR35","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1161\/CIRCULATIONAHA.112.000855","volume":"127","author":"K Kondo","year":"2013","unstructured":"Kondo, K. et al. H2S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase. Circulation 127, 1116\u20131127 (2013).","journal-title":"Circulation"},{"key":"69205_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12050437","author":"R Ravi","year":"2022","unstructured":"Ravi, R. et al. Metabolite Signature in the Carriers of Pathogenic Genetic Variants for Cardiomyopathy: A Population-Based METSIM Study. Metabolites https:\/\/doi.org\/10.3390\/metabo12050437 (2022).","journal-title":"Metabolites"},{"key":"69205_CR37","doi-asserted-by":"publisher","first-page":"W566","DOI":"10.1093\/nar\/gkv468","volume":"43","author":"T Metsalu","year":"2015","unstructured":"Metsalu, T. & Vilo, J. ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap. Nucl. Acids Res. 43, W566\u2013W570 (2015).","journal-title":"Nucl. Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69205-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69205-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69205-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T07:06:31Z","timestamp":1723532791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69205-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["69205"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-69205-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,13]]},"assertion":[{"value":"25 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18768"}}